STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.
about
STK33 participates to HSP90-supported angiogenic program in hypoxic tumors by regulating HIF-1α/VEGF signaling pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@en
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@nl
type
label
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@en
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@nl
prefLabel
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@en
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@nl
P2093
P2860
P356
P1433
P1476
STK33 participates to HSP90-su ...... HIF-1α/VEGF signaling pathway.
@en
P2093
Arefeh Rouhi
Gabriela Chiosis
Konrad Steinestel
Kristina Diepold
Milena Armacki
Ninel Azoitei
Thomas Seufferlein
Thomas Simmet
P2860
P304
77474-77488
P356
10.18632/ONCOTARGET.20535
P407
P577
2017-08-24T00:00:00Z